3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
2
Status
Completed
16
Terminated
2
Active not recruiting
2
Recruiting
1
Sponsor Class
INDUSTRY
2
Study Type
Interventional
2
Sponsor
Cancer Type
Other hematologic neoplasm
2
Lymphoid
2
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
15
Lymphoma, Large B-Cell, Diffuse
14
Lymphoma
12
Burkitt Lymphoma
12
Neoplasms
8
Lymphoma, Follicular
8
Lymphoma, B-Cell
6
Rhabdomyosarcoma
5
Medulloblastoma
5
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
4
Hodgkin Disease
4
Wilms Tumor
3
Retinoblastoma
3
Recurrence
3
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
3
Lymphoma, Non-Hodgkin
3
Lymphoma, B-Cell, Marginal Zone
3
Central Nervous System Neoplasms
3
Sarcoma, Ewing
2
Sarcoma
2
Rhabdomyosarcoma, Embryonal
2
Rhabdomyosarcoma, Alveolar
2
Rhabdoid Tumor
2
Neuroectodermal Tumors, Primitive
2
Lymphoproliferative Disorders
2
Lymphoma, Mantle-Cell
2
Lymphoma, AIDS-Related
2
Leukemia, Myeloid, Accelerated Phase
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Leukemia, Biphenotypic, Acute
2
Interventions
venetoclax
25
ibrutinib
23
Rituximab
22
Cyclophosphamide
21
obinutuzumab
18
acalabrutinib
18
fludarabine phosphate
13
fludarabine
13
zanubrutinib
8
Bendamustine Hydrochloride
8
pirtobrutinib
7
Biopsy
7
Specimen Handling
6
Lenalidomide
6
CT-P10
6
Whole-Body Irradiation
5
Tacrolimus
4
Peripheral Blood Stem Cell Transplantation
4
Mycophenolic Acid
4
duvelisib
3
Melphalan
3
Chlorambucil
3
Busulfan
3
idelalisib
2
daratumumab
2
Vincristine
2
Prednisone
2
Patient Reported Outcome Measures
2
Observation
2
Mesna
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Active not recruiting
×
Leukemia, Lymphocytic, Chronic, B-Cell
×
Vincristine
×
Clear all
NCT04542824
2026-05-05
EPCOREâ„¢ NHL-3
Genmab
Phase 1/2
Active not recruiting
78 enrolled
NCT04623541
2026-05-05
EPCOREâ„¢ CLL-1
Genmab
Phase 1/2
Active not recruiting
195 enrolled